1.Xu G, Xue Y, Özkurt ZG, Slimani N, Hu Z, Wang X, Xia K, Ma T, Zhou Q, Demirci HJPO: Photoacoustic imaging features of intraocular tumors: Retinoblastoma and uveal melanoma. PLoS ONE 2017, 12(2):e0170752.
2.Oberacker E, Paul K, Huelnhagen T, Oezerdem C, Winter L, Pohlmann A, Boehmert L, Stachs O, Heufelder J, Weber A et al: Magnetic resonance safety and compatibility of tantalum markers used in proton beam therapy for intraocular tumors: A 7.0 Tesla study. Magn Reson Med 2017, 78(4):1533–1546.
3.Daniel S, Monika S, Karl E, Elisabeth WJCO: Clinical, optical coherence tomography, and fundus autofluorescence findings in patients with intraocular tumors. Clin Ophthalmol 2016, 10:1953–1964.
4.Bornfeld N, Biewald E, Bauer S, Temming P, Lohmann D, Zeschnigk MJDAI: The Interdisciplinary Diagnosis and Treatment of Intraocular Tumors. Dtsch Arztebl Int 2018, 115(7):106.
5.Choi YJ, Kim TW, Kim S, Choung H, Lee MJ, Kim N, Khwarg SI, Yu YSJJoKMS: Effects on Periocular Tissues after Proton Beam Radiation Therapy for Intraocular Tumors. J Korean Med Sci 2018, 33(16).
6.Foley SW, Vandivier LE, Kuksa PP, Gregory BD: Transcriptome-wide measurement of plant RNA secondary structure. Current opinion in plant biology 2015, 27:36–43.
7.Grabherr MG, Haas BJ, Yassour M, Levin JZ, Thompson DA, Amit I, Adiconis X, Fan L, Raychowdhury R, Zeng Q et al: Full-length transcriptome assembly from RNA-Seq data without a reference genome. Nature biotechnology 2011, 29(7):644–652.
8.Zhang SH, Bian YN, Zhao Q, Li CT: [Review of Second Generation Sequencing and Its Application in Forensic Genetics]. Fa yi xue za zhi 2016, 32(4):282–289.
9.Potter SSJNRN: Single-cell RNA sequencing for the study of development, physiology and disease. Nat Rev Nephrol 2018, 14(8).
10.Das DK, Ali T, Krampis K, Ogunwobi OOJDiB: Fibronectin and androgen receptor expression data in prostate cancer obtained from a RNA-sequencing bioinformatics analysis. Data Brief 2017, 11(C):131–135.
11.Edgren H, Murumagi A, Kangaspeska S, Nicorici D, Hongisto V, Kleivi K, Rye IH, Nyberg S, Wolf M, Borresendale ALJGB: Identification of fusion genes in breast cancer by paired-end RNA-sequencing. Genome Biol 2011, 12(1):R6.
12.Pan WK, Zhang YF, Yu H, Gao Y, Zheng BJ, Li P, Xie C, Ge XJWJoP: Identifying key genes associated with Hirschsprung’s disease based on bioinformatics analysis of RNA-sequencing data. World J Pediatr 2017, 13(3):1–7.
13.Roy J, Sarkar A, Parida S, Ghosh Z, Mallick BJMB: Small RNA sequencing revealed dysregulated piRNAs in Alzheimer’s disease and their probable role in pathogenesis. Molecular BioSystems 2017, 13(3).
14.Sharron LX, Hu L, Sandy K, Correll M, Quackenbush J, Wu CL, Scott MWJUO: Differentiating progressive from nonprogressive T1 bladder cancer by gene expression profiling: applying RNA-sequencing analysis on archived specimens. Urologic Oncology 2013, 32(3):327–336.
15.Sun Y, Zhang D, Sun G, Lv Y, Li Y, Li X, Song Y, Li J, Fan Z, Wang HJC et al: RNA-sequencing study of peripheral blood mononuclear cells in sporadic Meniere’s disease patients: possible contribution of immunologic dysfunction to the development of this disorder. Clinical & Experimental Immunology 2017, 192(1).
16.Wu H, Humphreys BDJKI: The promise of single-cell RNA sequencing for kidney disease investigation. Kidney International 2017, 92(6).
17.Qiaolin D, Daniel RL, Bj?Rn R, Rickard SJS: Single-cell RNA-seq reveals dynamic, random monoallelic gene expression in mammalian cells. Science 2014, 343(6167):193–196.
18.Bloom JS, Khan Z, Kruglyak L, Singh M, Caudy AAJBG: Measuring differential gene expression by short read sequencing: quantitative comparison to 2-channel gene expression microarrays. BMC Genomics 2009, 10(1):221–221.
19.Alexa A, Rahnenfuhrer JJRPV: topGO: Enrichment analysis for Gene Ontology. 2006.
20.Vasalaki M, Fabian ID, Reddy MA, Cohen VM, Sagoo MSJBMB: Ocular oncology: advances in retinoblastoma, uveal melanoma and conjunctival melanoma. British Medical Bulletin 2017, 121(1).
21.Colleen CMMPH, Xiao-Cheng WMPH, Ph.D AJDVM, Howard JMPD, Ph.D LMRMPH, Vivien WCPDJC: Incidence of noncutaneous melanomas in the U.S. Cancer 2005, 103(5):1000–1007.
22.Group COMSJAO: Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Archives of ophthalmology 2001, 119(5):670–676.
23.SINGH, Arun D, TOPHAM, Ophthalmology AJ: Survival rates with uveal melanoma in the United States: 1973–1997. Ophthalmology 2003, 110(5):962–965.
24.Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, Abramson DH, Shields CL, Chantada GL, Njuguna FJNRDP: Retinoblastoma. Lancet 2012, 379(9824):1436–1446.
25.Friedman DL, Himelstein B, Shields CL, Shields JA, Needle M, Miller D, Bunin GR, Meadows ATJJoCO: Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 2000, 18(1):12–17.
26.Xu X, Jia R, Zhou Y, Song X, Wang J, Qian G, Ge S, Fan X: Microarray-based analysis: identification of hypoxia-regulated microRNAs in retinoblastoma cells. Int J Oncol 2011, 38(5):1385–1393.
27.Caltabiano R, Puzzo L, Barresi V, Ieni A, Loreto C, Musumeci G, Castrogiovanni P, Ragusa M, Foti P, Russo AJP-R et al: ADAM 10 expression in primary uveal melanoma as prognostic factor for risk of metastasis. Pathol Res Pract 2016, 212(11):980.
28.Zheng L LY, Pan J: Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt/β-catenin pathway %J 生物化学与生物物理学报:英文版. Acta Biochim Biophys Sin (Shanghai) 2017, 49(10):890–898.
29.Wang Y, Liu M, Jin Y, Jiang S, Pan JJCL: In vitro and in vivo anti-uveal melanoma activity of JSL–1, a novel HDAC inhibitor. Cancer letters 2017, 400.
30.Zhao Y, Zhang S, Zhang YJMMR: MicroRNA–320 inhibits cell proliferation, migration and invasion in retinoblastoma by targeting specificity protein 1. Molecular Medicine Reports 2017, 16(2):2191.
31.Shang W, Yang Y, Zhang J, Wu Q: Long noncoding RNA BDNF-AS is a potential biomarker and regulates cancer development in human retinoblastoma. Biochem Biophys Res Commun 2018, 497(4):1142–1148.
32.Li X, Yang L, Shuai T, Piao T, Wang RJB, Pharmacotherapy: MiR–433 inhibits retinoblastoma malignancy by suppressing Notch1 and PAX6 expression. Biomed Pharmacother 2016, 82:247–255.
33.Xing Z, Chu C, Chen L, Kong XJBEBA: The use of Gene Ontology terms and KEGG pathways for analysis and prediction of oncogenes. Biochimica et Biophysica Acta (BBA) - General Subjects 2016, 1860(11):2725–2734.